Kala Bio, Inc. (KALA)
0.569
+0.03
(+5.78%)
USD |
NASDAQ |
Sep 09, 12:39
Kala Bio Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | -3.456 |
| June 30, 2025 | -9.336 |
| March 31, 2025 | 5.667 |
| December 31, 2024 | 2.615 |
| September 30, 2024 | 5.400 |
| June 30, 2024 | 2.683 |
| March 31, 2024 | 5.489 |
| December 31, 2023 | 4.840 |
| September 30, 2023 | 3.215 |
| June 30, 2023 | 1.919 |
| March 31, 2023 | 1.418 |
| December 31, 2022 | 2.264 |
| September 30, 2022 | -44.08 |
| June 30, 2022 | -2.531 |
| March 31, 2022 | -15.28 |
| December 31, 2021 | 4.772 |
| September 30, 2021 | 1.741 |
| June 30, 2021 | 1.271 |
| March 31, 2021 | 0.9293 |
| Date | Value |
|---|---|
| December 31, 2020 | 1.009 |
| September 30, 2020 | 0.9525 |
| June 30, 2020 | 0.7837 |
| March 31, 2020 | 0.7146 |
| December 31, 2019 | 3.408 |
| September 30, 2019 | 2.351 |
| June 30, 2019 | 1.665 |
| March 31, 2019 | 1.234 |
| December 31, 2018 | 0.9473 |
| September 30, 2018 | 0.3621 |
| June 30, 2018 | 0.2933 |
| March 31, 2018 | 0.2497 |
| December 31, 2017 | 0.208 |
| September 30, 2017 | 0.1997 |
| June 30, 2017 | 0.885 |
| March 31, 2017 | 0.4526 |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -1.691 |
| September 30, 2015 | -8.076 |
| December 31, 2014 | 1.430 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.58M |
| Total Liabilities (Quarterly) | 1.538M |
| Shareholders Equity (Quarterly) | 9.044M |
| Current Ratio | 6.880 |
| Net Debt Paydown Yield | 19.34% |